Lars Skriver
Impact in
- Cancer Research top 0.2%
- Protease and Inhibitor Mechanisms
- Hematology top 0.5%
- Blood Coagulation and Thrombosis Mechanisms
Papers in
-
- Protease and Inhibitor Mechanisms 13
-
- Protein purification and stability 3
- Lipid Membrane Structure and Behavior 3
- Co-authors
- Keld Danø (12 shared papers)Lene Nielsen (9 shared papers)J Grøndahl-Hansen (6 shared papers)P.A. Andreasen (5 shared papers)Peter Lommer Kristensen (1 shared paper)Lars S. Nielsen (4 shared papers)Guy A. Thompson (4 shared papers)Peter Kristensen (3 shared papers)
- Journals
- Biochemistry (3 papers)The EMBO Journal (2 papers)Journal of Biological Chemistry (2 papers)FEBS Letters (2 papers)The Journal of Cell Biology (2 papers)
- Partner nations
- DenmarkUnited StatesGermany
In The Last Decade
Lars Skriver
31 papers receiving 4.0k citations
Lars Skriver's Hit Papers
Peers
Comparison fields: 5 of 111
- Cancer Research 2.9k
- Hematology 1.7k
- Immunology and Allergy 826
- Biotechnology 328
- Oncology 932
Countries citing papers authored by Lars Skriver
This map shows the geographic impact of Lars Skriver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Skriver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Skriver more than expected).
Fields of papers citing papers by Lars Skriver
This network shows the impact of papers produced by Lars Skriver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Skriver. The network helps show where Lars Skriver may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Skriver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Plasminogen Activators, Tissue Degradation, and Cancer Hit paper breakdown → | 1985 | 2298 |
| 2 | 1982 | 220 | |
| 3 | 1986 | 208 | |
| 4 | 1988 | 203 | |
| 5 | 1984 | 158 | |
| 6 | 1984 | 154 | |
| 7 | 1976 | 141 | |
| 8 | 1982 | 92 | |
| 9 | 1976 | 90 | |
| 10 | 1979 | 72 | |
| 11 | 1984 | 70 | |
| 12 | 1996 | 62 | |
| 13 | 1986 | 58 | |
| 14 | 1983 | 58 | |
| 15 | 1985 | 48 | |
| 16 | 2021 | 45 | |
| 17 | 1986 | 42 | |
| 18 | 1979 | 33 | |
| 19 | 1993 | 27 | |
| 20 | 1992 | 23 |
About Lars Skriver
Lars Skriver is a scholar working on Cancer Research, Molecular Biology, Oncology, Endocrinology, Diabetes and Metabolism and Biotechnology, having authored 31 papers that have together received 4.2k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (13 papers), Peptidase Inhibition and Analysis (7 papers), Growth Hormone and Insulin-like Growth Factors (7 papers), Enzyme Production and Characterization (5 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Lipid metabolism and biosynthesis (3 papers), Protein purification and stability (3 papers) and Lipid Membrane Structure and Behavior (3 papers). The work is most often cited by research in Cancer Research (2.9k citations), Hematology (1.7k citations), Immunology and Allergy (826 citations), Biotechnology (328 citations) and Oncology (932 citations). Lars Skriver has collaborated with scholars based in Denmark, United States and Germany. Frequent co-authors include Keld Danø, Lene Nielsen, J Grøndahl-Hansen, P.A. Andreasen, Peter Lommer Kristensen, Lars S. Nielsen, Guy A. Thompson, Peter Kristensen, Jesper Zeuthen and Lars Larsson. Their work appears in journals such as Biochemistry, The EMBO Journal, Journal of Biological Chemistry, FEBS Letters and The Journal of Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.